3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
3
Not yet recruiting
2
Approved for marketing
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
CNS
2
Conditions
Glioma
2
Lymphoma, Follicular
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
4
vorasidenib
2
Lomustine
2
Blood Specimen Collection
2
trametinib
1
tovorafenib
1
posaconazole
1
perillyl alcohol
1
pembrolizumab
1
niraparib
1
mirdametinib
1
gallium maltolate
1
dabrafenib
1
cemiplimab
1
Urination
1
Transurethral Resection of Bladder
1
Standard of Care
1
Spinal Puncture
1
Specimen Handling
1
Sitagliptin Phosphate
1
Receptors, Interleukin-8B
1
Radiotherapy
1
Radiation
1
Positron Emission Tomography Computed Tomography
1
Physical Therapy Modalities
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Ketoconazole
1
Histocompatibility Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Glioma
×
vorasidenib
×
Clear all
NCT07629089
2026-06-05
VALIENT
University of Pittsburgh
Phase 1
Not yet recruiting
24 enrolled
NCT06969352
2025-05-13
VICTORIA
Servier (Tianjin) Pharmaceutical Co. LTD.
Not yet recruiting
60 enrolled